Estrogen replacement therapy at menopause. How benefits outweigh risks
- PMID: 7937412
Estrogen replacement therapy at menopause. How benefits outweigh risks
Abstract
Bone loss and cardiovascular disease are the most important complications of menopause. Because estrogen has been shown to prevent bone loss and also reduce fracture rates in menopausal women, the authors recommend early replacement therapy. They also examine evidence that estrogen replacement may offer these women protection from cardiovascular disease and discuss the risks of estrogen-related endometrial and breast cancer.
Similar articles
-
Estrogen-replacement therapy in younger women with breast cancer.J Natl Cancer Inst Monogr. 1994;(16):149-52. J Natl Cancer Inst Monogr. 1994. PMID: 7999457 Review.
-
Estrogen replacement therapy in the elderly.Zentralbl Gynakol. 1996;118(5):255-61. Zentralbl Gynakol. 1996. PMID: 8701621 Review.
-
[Menopause and hormone replacement therapy].Orv Hetil. 2000 Mar 12;141(11):547-56. Orv Hetil. 2000. PMID: 10741167 Review. Hungarian.
-
Menopause: advanced management strategies.Curr Opin Obstet Gynecol. 1991 Jun;3(3):343-51. Curr Opin Obstet Gynecol. 1991. PMID: 1813002 Review.
-
Update: the latest on hormone replacement therapy.J Am Osteopath Assoc. 2000 Oct;100(10 Su Pt 1):S2-5. J Am Osteopath Assoc. 2000. PMID: 11105456 Review.
Cited by
-
The aging human lens: structure, growth, and physiological behaviour.Br J Ophthalmol. 1997 Oct;81(10):818-23. doi: 10.1136/bjo.81.10.818. Br J Ophthalmol. 1997. PMID: 9486018 Free PMC article. Review. No abstract available.
-
Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy.Osteoporos Int. 1997;7(3):213-8. doi: 10.1007/BF01622291. Osteoporos Int. 1997. PMID: 9205633 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical